Redx Pharma Plc (LON:REDX) shares soared as the company announced that Iain Ross, its executive chairman, has today acquired 150,000 Redx oridinary shares at a price of 11p per share.
The drug developer said following this acquisition, Iain Ross will hold 600,000 ordinary shares in the company, representing 0.47% of the issued share capital.
Yesterday Redx Pharma's shares jumped 48% as the company announced the appointment of AstraZeneca PLC (LON:AZN) Lisa Anson as its new chief executive.
READ: Redx Pharma shares soar 48% after it recruits heavy hitter from drugs major AstraZeneca
In lunchtime trading company’s shares soared 69.2% to 16.5p.